Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971.

Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the newer formulation contains albumin-bound paclitaxel marketed under the brand name Abraxane.

A：Yes. Currently, researchers have developed a nanoparticle-based concentrate for injection (Nab-paclitaxel), which is a water-soluble formulation of paclitaxel.

A：Paclitaxel is a widely used drug developed since the mid-1980s, with significant antitumor activity against ovarian, head and neck, bladder, breast and lung cancers.